OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Director exercised or converted 50K PBYI derivative securities | OQRO

Home
Insider trades
Puma Biotechnology
Director exercised or converted 50K PBYI derivative securities

Insider trades

Insider trade

Director exercised or converted 50K PBYI derivative securities

Traded Sep 14, 2026 · Filed Sep 17, 2026

PBYPuma BiotechnologyPBYI

50K
Derivative units

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Sep 14, 2026
Reporting period: Not applicable
Filed with the SEC: Sep 17, 2026

DirectorOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001437749-26-030593

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Sep 17, 2026, 5:06 AM UTC

Added to OQRO

Oct 7, 2026, 5:52 AM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

PUMA BIOTECHNOLOGY, INC.

Issuer CIK

1401667

Ticker

PBYI

Reporting person

Alessandra Cesano

Relationship

Director

Security

Stock Option

Table

Derivative (Table II)

Transaction date

Sep 14, 2026

Transaction code

Shares / units

50,000

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

50,000

Ownership form

Direct

Amendment

Footnotes from the filing

The Stock Option is fully vested.

Around the same time

Troy Edward Wilson (Director) sold ~$46K of Puma Biotechnology

Scheduled in advanceFiled 3w ago

Alessandra CesanoDirector

Filed 3w ago

50KShares · @ $2.93

Traded Sep 14 · filed 3 days later

Derivative exercise or conversion — not an open-market buy.

More Official record

Alessandra Cesano (Director) sold ~$567K of Puma Biotechnology

Scheduled in advanceFiled 3w ago